TrialLeukemia2017

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study.

A Hochhaus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.